THERAPIX BIOSCI/S (NASDAQ:TRPX) Stock Price Down 10.8%

THERAPIX BIOSCI/S (NASDAQ:TRPX)’s stock price was down 10.8% on Monday . The company traded as low as $1.41 and last traded at $1.41, approximately 511,521 shares changed hands during trading. An increase of 596% from the average daily volume of 73,504 shares. The stock had previously closed at $1.58.

The stock’s 50-day moving average is $2.10 and its two-hundred day moving average is $2.47.

About THERAPIX BIOSCI/S (NASDAQ:TRPX)

Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110 for the treatment of Tourette syndrome, Obstructive Sleep Apnea, and pain; THX-130 for the treatment of Mild Cognitive Impairment and Traumatic Brain Injury; THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Featured Story: Market Perform

Receive News & Ratings for THERAPIX BIOSCI/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for THERAPIX BIOSCI/S and related companies with MarketBeat.com's FREE daily email newsletter.